Over the past 30 years, our industry has made significant strides in combating cardiovascular disease (CVD), yet it remains the leading cause of death worldwide since 1980. With over two decades of experience in the pharmaceutical industry, I’ve dedicated my career to advancing healthcare through innovation, strategic leadership, and an unwavering commitment to improving patient outcomes.As Senior Vice President of US Cardiovascular and Established Brands at Bristol Myers Squibb, I have the privilege of leading a dynamic team. Together, we are deeply committed to addressing the global burden of CVD by developing new medicines. Building on our 70-year legacy of pioneering paradigm-shifting treatments, we are leveraging decades of expertise to elevate cardiovascular research and breakthroughs.I believe in the power of connecting innovative science with the healthcare professionals, patient advocates, and decision-makers who can influence the future of CVD care. My mission is to lead the charge in developing and delivering therapies that address the full spectrum of cardiovascular diseases, ultimately improving the lives of patients worldwide.#Cardiovascular #CVD #Innovation #PatientCare #Leadership